Renaissance Technologies (RenTech)'s SRTS Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 242,334 shares of Sensus Healthcare, Inc. (SRTS) worth $731,849, representing 0.00% of the portfolio. First purchased in 2017-Q3, this long-term strategic position has been held for 31 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in SRTS, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 150,200 shares. Largest reduction occurred in Q1 2025, reducing 171,300 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Sensus Healthcare (SRTS) Holding Value Over Time
Track share changes against reported price movement
Quarterly Sensus Healthcare (SRTS) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | -9,900 | Reduce 3.92% | 242,334 | $3.02 |
| Q1 2026 | -4,800 | Reduce 1.87% | 252,234 | $3.98 |
| Q4 2025 | -4,100 | Reduce 1.57% | 257,034 | $3.98 |
| Q3 2025 | +11,000 | Add 4.40% | 261,134 | $3.14 |
| Q2 2025 | -9,500 | Reduce 3.66% | 250,134 | $4.74 |
| Q1 2025 | -171,300 | Reduce 39.75% | 259,634 | $4.73 |
| Q4 2024 | +21,600 | Add 5.28% | 430,934 | $6.92 |
| Q3 2024 | +17,800 | Add 4.55% | 409,334 | $5.80 |
| Q2 2024 | +100,294 | Add 34.44% | 391,534 | $5.33 |
| Q1 2024 | +492 | Add 0.17% | 291,240 | $3.80 |
| Q4 2023 | -41,525 | Reduce 12.50% | 290,748 | $2.36 |
| Q3 2023 | -35,661 | Reduce 9.69% | 332,273 | $2.77 |
| Q2 2023 | +91,800 | Add 33.24% | 367,934 | $0.00 |
| Q1 2023 | +97,400 | Add 54.49% | 276,134 | $0.01 |
| Q4 2022 | -87,300 | Reduce 32.82% | 178,734 | $0.01 |
| Q3 2022 | +52,600 | Add 24.64% | 266,034 | $12.53 |
| Q2 2022 | -98,700 | Reduce 31.62% | 213,434 | $7.68 |
| Q1 2022 | +150,200 | Add 92.75% | 312,134 | $10.12 |
| Q4 2021 | +139,900 | Add 634.93% | 161,934 | $7.22 |
| Q3 2021 | +200 | Add 0.92% | 22,034 | $3.59 |
| Q2 2021 | +300 | Add 1.39% | 21,834 | $3.85 |
| Q1 2021 | +3,100 | Add 16.82% | 21,534 | $3.81 |
| Q4 2020 | +5,800 | Add 45.91% | 18,434 | $3.85 |
| Q3 2020 | +1,400 | Add 12.46% | 12,634 | $2.53 |
| Q2 2020 | +11,234 | New Buy | 11,234 | $3.03 |
| Q4 2018 | -48,100 | Sold Out | 0 | $0.00 |
| Q3 2018 | +20,612 | Add 74.99% | 48,100 | $8.38 |
| Q2 2018 | +16,088 | Add 141.12% | 27,488 | $7.28 |
| Q1 2018 | +1,100 | Add 10.68% | 11,400 | $5.88 |
| Q4 2017 | -16,739 | Reduce 61.91% | 10,300 | $5.15 |
| Q3 2017 | +27,039 | New Buy | 27,039 | $4.99 |
Renaissance Technologies (RenTech)'s Sensus Healthcare Investment FAQs
Renaissance Technologies (RenTech) first purchased Sensus Healthcare, Inc. (SRTS) in Q3 2017, acquiring 27,039 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Sensus Healthcare, Inc. (SRTS) for 31 quarters since Q3 2017.
Renaissance Technologies (RenTech)'s largest addition to Sensus Healthcare, Inc. (SRTS) was in Q1 2022, adding 312,134 shares worth $3.16 M.
According to the latest 13F filing for Q2 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 242,334 shares of Sensus Healthcare, Inc. (SRTS), valued at approximately $731,849.
As of the Q2 2026 filing, Sensus Healthcare, Inc. (SRTS) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Sensus Healthcare, Inc. (SRTS) was 430,934 shares, as reported at the end of Q4 2024.